New Zealand has one of the highest rates of melanoma in the world but lags in funding novel drugs that […]
Continue readingmelanoma
Pharmac confirms funding for melanoma drug – In the News
Drug-buying agency Pharmac officially announced funding for the melanoma treatment Keytruda on Tuesday. It followed a provisional decision in June […]
Continue readingMelanoma mutations vary North to South – In the News
New Zealand has the highest rates of melanoma in the world but the underlying genetic changes behind these cancers vary […]
Continue readingKiwi teens sizzle in the sun – In the News
New Zealand teens are shirking sun-smart clothing and the grown-ups looking after them are not doing much better, according to […]
Continue readingPHARMAC needs funding boost – Dr Francis Hunter
Writing on Stuff.co.nz* the University of Auckland’s Dr Francis Hunter outlines the situation PHARMAC and the Government face over the […]
Continue readingPush for Keytruda funding – Expert reaction
Public pressure is growing for the Government to fund the melanoma drug Keytruda, listed as ‘low priority’ by drug funding […]
Continue readingPHARMAC not to fund melanoma drug – In the News
PHARMAC’s decision not to fund melanoma treatment pembrolizumab – marketed as Keytruda – has been widely covered in the media. Public […]
Continue readingCancer: the cost of a life – NZH special series
This week the New Zealand Herald has run an extensive five-part series – in print and online – delving deep […]
Continue readingNew melanoma drug in the headlines
A promising melanoma drug has doctors and patient groups calling for the medicine to be funded by PHARMAC in New […]
Continue readingNew viral immunotherapy for skin cancer completes phase 3 trials – Expert Reaction
A new drug that specifically targets cancer cells has shown promising results in phase three clinical trials. A genetically-modified herpes virus injected into […]
Continue reading